Keros Therapeutics, Inc. (KROS)
11.61
-0.34
(-2.85%)
USD |
NASDAQ |
Oct 12, 16:00
11.61
0.00 (0.00%)
After-Hours: 17:12
Keros Therapeutics EPS Diluted (Quarterly) : -1.45 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.45 |
| March 31, 2026 | -1.208 |
| December 31, 2025 | -0.8626 |
| September 30, 2025 | -0.1792 |
| June 30, 2025 | -0.7558 |
| March 31, 2025 | 3.619 |
| December 31, 2024 | -1.141 |
| September 30, 2024 | -1.409 |
| June 30, 2024 | -1.254 |
| March 31, 2024 | -1.208 |
| December 31, 2023 | -1.336 |
| September 30, 2023 | -1.329 |
| June 30, 2023 | -1.267 |
| March 31, 2023 | -1.262 |
| December 31, 2022 | -1.088 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.9201 |
| June 30, 2022 | -1.134 |
| March 31, 2022 | -1.008 |
| December 31, 2021 | -0.2961 |
| September 30, 2021 | -0.8688 |
| June 30, 2021 | -0.6703 |
| March 31, 2021 | -0.6838 |
| December 31, 2020 | -0.4937 |
| September 30, 2020 | -0.5963 |
| June 30, 2020 | -0.622 |
| March 31, 2020 | -0.6302 |
| December 31, 2019 | -0.1589 |
| September 30, 2019 | -0.1985 |
| June 30, 2019 | -1.444 |
| March 31, 2019 | -0.1803 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Incyte Corp. | 2.812 |
| Viking Therapeutics, Inc. | -1.101 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.71M |
| Total Expenses (Quarterly) | 28.71M |
| Enterprise Value | -4.947M |
| Earnings Yield | -31.87% |
| Normalized Earnings Yield | -31.85 |